JP2017512304A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512304A5
JP2017512304A5 JP2016550561A JP2016550561A JP2017512304A5 JP 2017512304 A5 JP2017512304 A5 JP 2017512304A5 JP 2016550561 A JP2016550561 A JP 2016550561A JP 2016550561 A JP2016550561 A JP 2016550561A JP 2017512304 A5 JP2017512304 A5 JP 2017512304A5
Authority
JP
Japan
Prior art keywords
biomarker
pair
immune system
determining
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016550561A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017512304A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/050043 external-priority patent/WO2015117204A1/en
Publication of JP2017512304A publication Critical patent/JP2017512304A/ja
Publication of JP2017512304A5 publication Critical patent/JP2017512304A5/ja
Pending legal-status Critical Current

Links

JP2016550561A 2014-02-06 2015-02-06 バイオマーカーシグネチャー法ならびにそのための装置およびキット Pending JP2017512304A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014900363A AU2014900363A0 (en) 2014-02-06 Biomarker Signature Method, and Apparatus and Kits Therefor
AU2014900363 2014-02-06
PCT/AU2015/050043 WO2015117204A1 (en) 2014-02-06 2015-02-06 Biomarker signature method, and apparatus and kits therefor

Publications (2)

Publication Number Publication Date
JP2017512304A JP2017512304A (ja) 2017-05-18
JP2017512304A5 true JP2017512304A5 (cg-RX-API-DMAC7.html) 2018-04-19

Family

ID=53754326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550561A Pending JP2017512304A (ja) 2014-02-06 2015-02-06 バイオマーカーシグネチャー法ならびにそのための装置およびキット

Country Status (8)

Country Link
US (4) US11047010B2 (cg-RX-API-DMAC7.html)
EP (1) EP3103046B1 (cg-RX-API-DMAC7.html)
JP (1) JP2017512304A (cg-RX-API-DMAC7.html)
CN (1) CN105981026A (cg-RX-API-DMAC7.html)
AU (1) AU2015213486B2 (cg-RX-API-DMAC7.html)
CA (1) CA2930925A1 (cg-RX-API-DMAC7.html)
DK (1) DK3103046T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015117204A1 (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105518153A (zh) 2013-06-20 2016-04-20 因姆内克斯普雷斯私人有限公司 生物标志物鉴定
WO2015117204A1 (en) 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor
US20180107783A1 (en) * 2015-05-28 2018-04-19 Immunexpress Pty Ltd Validating biomarker measurement
DK3356558T3 (da) 2015-09-30 2022-04-25 Immunexpress Pty Ltd Sirs patogenbiomarkører og anvendelser deraf
AU2016349950B2 (en) * 2015-11-06 2022-10-06 Immunexpress Pty Ltd Viral biomarkers and uses therefor
CN106701900B (zh) * 2015-11-16 2020-03-20 上海市东方医院 长链非编码rna herc2p3基因及其在胃癌中的用途
CN105256063B (zh) * 2015-12-01 2019-03-01 北京泱深生物信息技术有限公司 肿瘤标志物dmbx1及其应用
US20200371099A1 (en) 2015-12-24 2020-11-26 Immunexpress Pty Ltd Triage biomarkers and uses therefor
CN105506172B (zh) * 2016-03-01 2019-04-09 北京泱深生物信息技术有限公司 含检测gfod2的骨质疏松血液诊断试剂及其应用
JP2019511057A (ja) * 2016-03-23 2019-04-18 ピーチ インテリヘルス,インコーポレイティド Sirsの予測のための臨床パラメータの使用
WO2018035563A1 (en) * 2016-08-24 2018-03-01 Immunexpress Pty Ltd Systemic inflammatory and pathogen biomarkers and uses therefor
GB201616557D0 (en) * 2016-09-29 2016-11-16 Secretary Of State For Health The Assay for distinguishing between sepsis and systemic inflammatory response syndrome
CN110191960A (zh) * 2016-11-08 2019-08-30 克维拉公司 进行核酸稳定和分离的方法
CN106755343A (zh) * 2016-12-01 2017-05-31 北京致成生物医学科技有限公司 胰腺癌预后诊断分子标记物
WO2018131274A1 (ja) * 2017-01-16 2018-07-19 株式会社島津製作所 データ解析装置及びデータ解析用プログラム
WO2018140256A1 (en) * 2017-01-17 2018-08-02 Duke University Gene expression signatures useful to predict or diagnose sepsis and methods of using the same
CN108341862B (zh) * 2017-01-24 2021-04-02 上海交通大学医学院附属仁济医院 一种多肽及其应用
CN106947808B (zh) * 2017-03-10 2020-07-24 北京赛尔得生物技术有限公司 Tmem104基因在制备治疗椎间盘退行性疾病药物中的应用
CN107133475B (zh) * 2017-05-10 2020-09-29 浙江省立同德医院 一种中药注射剂不良反应高危患者模式识别方法
CN111033631B (zh) * 2017-06-13 2024-03-12 波士顿基因公司 用于生成分子功能谱、对其进行可视化和分类的系统和方法
CA3095354A1 (en) 2017-11-15 2019-05-23 Universite Laval Use of srsf3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
CN108467890A (zh) * 2018-05-02 2018-08-31 首都医科大学附属北京天坛医院 Vat1基因及vat1基因的干扰物的应用和应用vat1基因的产品
CN108753834B (zh) * 2018-05-28 2021-11-23 上海海洋大学 ddx27基因缺失斑马鱼突变体的制备方法
US20210388443A1 (en) * 2018-11-05 2021-12-16 Institute For Systems Biology Sepsis biomarker panels and methods of use
US12548678B2 (en) 2020-05-14 2026-02-10 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
EP3881233A4 (en) * 2018-11-15 2022-11-23 Ampel Biosolutions, LLC DISEASE PREDICTION AND TREATMENT PRIORIZATION WITH MACHINE LEARNING
AU2019404302A1 (en) 2018-12-19 2021-08-05 The Trustees Of The University Of Pennsylvania Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor t cells against t cell lymphomas and leukemias
CN111443065A (zh) * 2019-01-17 2020-07-24 四川大学华西医院 一种肺癌的筛查试剂盒
CN109762911B (zh) * 2019-02-21 2020-12-01 华中农业大学 Ptprj基因作为猪免疫相关性状的分子标记及其应用
JP7600138B2 (ja) 2019-03-19 2024-12-16 オプティナ・ダイアグノスティクス・インコーポレイテッド 病状によって影響を受ける可能性がある被験者を識別するための方法およびシステム
CN112409376A (zh) * 2019-08-20 2021-02-26 华东师范大学 一种基于dcaf15的蛋白降解靶向嵌合体及其制备方法和应用
CN110567861B (zh) * 2019-09-09 2021-12-21 浙江普罗亭健康科技有限公司 基于质谱流式检测技术筛查具有免疫原性抗原肽的试剂盒及检测方法
CN110558279B (zh) * 2019-09-16 2021-11-16 南方科技大学 一种药物筛选模型、药物筛选方法及其应用
CN110687285B (zh) * 2019-10-29 2023-03-21 安徽医科大学 诊断试剂盒及mak16在制备系统性红斑狼疮早期诊断试剂中的应用
EP3819387A1 (en) * 2019-11-08 2021-05-12 Alcediag Differential diagnosis of bipolar disorder and unipolar depression by blood rna editing biomarkers
CN110791523B (zh) * 2019-12-13 2022-05-10 南京农业大学 一种棉花抗旱相关基因GhRCHY1及其应用
CN111276248B (zh) * 2020-01-20 2023-09-12 苏州帕诺米克生物医药科技有限公司 状态确定系统和电子设备
CN114317746B (zh) * 2020-03-30 2022-09-23 中国医学科学院肿瘤医院 外泌体arpc5、ypel2等在肺癌诊断中的应用
CN114487402A (zh) * 2020-11-12 2022-05-13 首都医科大学附属北京世纪坛医院 尿液非分泌核糖核酸酶蛋白及其多肽片段在妊娠糖尿病中的应用
CN112553322B (zh) * 2020-12-25 2022-07-05 深圳市人民医院 一种骨质疏松诊断标志物及其应用
EP4291899A1 (en) * 2021-02-11 2023-12-20 EDP Biotech Corporation Kits and methods for detecting markers and determining the presence or risk of cancer
CN113125757B (zh) * 2021-04-22 2022-10-28 石河子大学 一种用于母猪早期妊娠诊断的蛋白生物标志物及其用于母猪早期妊娠检测的方法
WO2022226267A1 (en) * 2021-04-23 2022-10-27 Alnylam Pharmaceuticals, Inc. iRNA COMPOSITIONS AND METHODS FOR SILENCING CHITINASE 3-LIKE PROTEIN 1/YKL-40 (CHI3L1/YKL-40) PROTEIN
CN117751195A (zh) * 2021-05-25 2024-03-22 不列颠哥伦比亚大学 脓毒症内型和/或严重程度的诊断
WO2023034111A1 (en) * 2021-08-30 2023-03-09 Inflammatix, Inc. A baseline gene expression-based prognostic for anti-tnf alpha therapy response in patients with inflammatory bowel disease
US20240425925A1 (en) * 2021-10-29 2024-12-26 GenoDx Pty Ltd Biomarkers and uses therefor
CN114875144B (zh) * 2022-04-02 2026-04-17 及智(苏州)医学技术有限公司 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
WO2023224913A1 (en) * 2022-05-16 2023-11-23 Cz Biohub Sf, Llc Integrated host-microbe metagenomics of cell-free nucleic acid for sepsis diagnosis
EP4471784A1 (fr) * 2023-05-31 2024-12-04 Biomérieux Procede et systeme de typage probabiliste de souches microbiennes
EP4471785A1 (fr) * 2023-05-31 2024-12-04 Biomérieux Procede et systeme de typage probabiliste de souches microbiennes
WO2025257393A1 (en) * 2024-06-14 2025-12-18 Roche Diagnostics Gmbh Method and system for improving biomarker based disease assessments
CN119842884B (zh) * 2025-01-09 2025-09-19 湖北文理学院 Tm9sf1在制备用于监测脓毒症病程的试剂中的应用
CN120405150B (zh) * 2025-07-01 2025-11-18 南昌大学第一附属医院 Itga6在制备脓毒症诊断及病情监测试剂或试剂盒中的应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980488A7 (fi) * 1998-03-04 1999-09-05 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
US20070134261A1 (en) 2001-12-03 2007-06-14 Hancock Robert E Effectors of innate immunity
JP2004041121A (ja) * 2002-07-12 2004-02-12 Hitachi Ltd アレルギー解析方法及びシステム
US20040096917A1 (en) 2002-11-12 2004-05-20 Becton, Dickinson And Company Diagnosis of sepsis or SIRS using biomarker profiles
CN1829730A (zh) * 2002-11-12 2006-09-06 贝克顿迪金森公司 使用生物标记谱诊断脓毒或者sirs
EP1611255A2 (de) 2003-04-02 2006-01-04 SIRS-Lab GmbH Verfahren zur erkennung akuter generalisierter entzündlicher zustände (sirs), sepsis, sepsis ähnlichen zuständen und systemischen infektionen
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
JP2007518062A (ja) * 2003-09-29 2007-07-05 バイオサイト インコーポレイテッド 敗血症を診断する方法および診断するための組成物
DE102004009952B4 (de) 2004-03-01 2011-06-01 Sirs-Lab Gmbh Verfahren zur Erkennung von Sepsis
ES2439229T3 (es) 2004-10-06 2014-01-22 The Brigham And Women's Hospital, Inc. Relevancia de niveles logrados de marcadores de inflamación sistémica tras el tratamiento
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン,ディッキンソン アンド カンパニー 敗血症の診断
AU2006259583A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
DE102005050933A1 (de) * 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US20090297474A1 (en) * 2005-11-25 2009-12-03 Dermot Kelleher Method for Detecting or Monitoring Sepsis by Analysing Cytokine mRNA Expression Levels
US8014957B2 (en) 2005-12-15 2011-09-06 Fred Hutchinson Cancer Research Center Genes associated with progression and response in chronic myeloid leukemia and uses thereof
US20070255113A1 (en) 2006-05-01 2007-11-01 Grimes F R Methods and apparatus for identifying disease status using biomarkers
WO2008021115A2 (en) 2006-08-14 2008-02-21 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
WO2009030770A2 (en) * 2007-09-07 2009-03-12 Universite Libre De Bruxelles Methods and tools for prognosis of cancer in er- patients
EP2188630A4 (en) * 2007-10-02 2010-11-03 Univ Rochester METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC ANSWERS TO ONCOGENIC MUTATIONS
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
DE102008000715B9 (de) 2008-03-17 2013-01-17 Sirs-Lab Gmbh Verfahren zur in vitro Erfasssung und Unterscheidung von pathophysiologischen Zuständen
JP2009229340A (ja) * 2008-03-25 2009-10-08 Sysmex Corp 全身性炎症反応症候群の重症度に関する情報を生成する方法及び装置
US20110306514A1 (en) * 2009-01-14 2011-12-15 United States Department of Health and Human Services Ratio based biomarkers and methods of use thereof
EP2452194B1 (en) 2009-07-10 2015-11-11 Transgene SA Biomarker for selecting patients and related methods
US20110076685A1 (en) 2009-09-23 2011-03-31 Sirs-Lab Gmbh Method for in vitro detection and differentiation of pathophysiological conditions
US20110312521A1 (en) * 2010-06-17 2011-12-22 Baylor Research Institute Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases
AU2011334548B2 (en) * 2010-11-26 2016-06-09 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
AU2012308365A1 (en) 2011-09-16 2014-04-24 Cepheid Methods of detecting sepsis
CA2895133A1 (en) 2012-12-13 2014-06-19 Baylor Research Institute Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis
CN105518153A (zh) * 2013-06-20 2016-04-20 因姆内克斯普雷斯私人有限公司 生物标志物鉴定
WO2015117204A1 (en) 2014-02-06 2015-08-13 Immunexpress Pty Ltd Biomarker signature method, and apparatus and kits therefor

Similar Documents

Publication Publication Date Title
Yeri et al. Evaluation of commercially available small RNASeq library preparation kits using low input RNA
Bender et al. Quantification of variation and the impact of biomass in targeted 16S rRNA gene sequencing studies
Hoy et al. Parasite-derived microRNAs in host serum as novel biomarkers of helminth infection
Mick et al. Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2
JP2018514189A5 (cg-RX-API-DMAC7.html)
EP3729439B1 (en) Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
US20190355438A1 (en) Inferring selection in white blood cell matched cell-free dna variants and/or in rna variants
JP7060518B2 (ja) 早産転帰に対する早期リスク評価のための方法及びシステム
HK1257433A1 (zh) 免疫組庫正常性評估方法及其應用
JP2018525703A5 (cg-RX-API-DMAC7.html)
JP2022502027A (ja) 複数のbespokeスパイクイン混合物を介した、微生物叢の配列処理および示差的存在量分析を検証するための、組成物、システム、装置、および方法
JP2019535286A (ja) 乳がん患者の化学治療の有用性を予測する方法
US12499972B2 (en) Identifying false positive variants using a significance model
WO2014187884A2 (en) Mirnas as non-invasive biomarkers for heart failure
CN117587145A (zh) 免疫年龄预测的生物标志物、方法、系统、介质、电子设备及诊断试剂盒
US20170145501A1 (en) Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
CN105779580A (zh) 评估罹患结肠直肠癌风险的方法及标志物
CN117587144B (zh) 一种基于普通转录组测序方法的免疫相关生物标志物、试剂盒和免疫年龄预测模型
CN119307603A (zh) 脓毒症凝血相关预后标志基因及其在制备脓毒症预后预测诊断产品中的应用
CN114566224B (zh) 一种用于鉴别或区分不同海拔人群的模型及其应用
CN105177130B (zh) 用来评估艾滋病人发生免疫重建炎性综合症的标志物
Habara circRNA signatures distinguishing COVID-19 outcomes and acute respiratory distress syndrome: a longitudinal, two-timepoint, precision-weighted analysis of a public RNA-Seq cohort
TWI718474B (zh) 評估個體罹患泌尿上皮癌之風險的方法及其套組
JP6296747B2 (ja) ヒト唾液細菌叢の検査によるIgA腎症の診断方法
CN116064773B (zh) 一组用于检测血铅诱导儿童智力降低的生物标志物及其应用